ArticlePloS one2016

HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy.

Albina Stocker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.